BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15062167)

  • 21. [Technique of intraoperative planning in prostatic brachytherapy with permanent implants of 125I or 103Pd].
    Prada Gómez PJ; Juan Rijo G; Hevia Suarez M; Abascal García JM; Abascal García R
    Arch Esp Urol; 2002 Dec; 55(10):1217-23; discussion 1223-4. PubMed ID: 12611219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Brachytherapy for prostate cancer: old concept, new techniques].
    Cosset JM; Flam T; Thiounn N; Rosenwald JC; Pontvert D; Timbert M; Solignac S; Chauveinc L
    Bull Cancer; 2006 Aug; 93(8):761-6. PubMed ID: 16935780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity].
    Pommier P; Delannes M; LeFloch O; Bernier V; Baron MH; Thomas L; Malet C; Bonnet J; Louisot P; Aletti P; Goubard O; Chemin A; Chirat F; Lebivic S; Montbarbon X; Bachaud JM; Votron L; Lasbareilles O; Desmettre O; Bringeon G; Gassa F; Peiffert D
    Cancer Radiother; 2006 Dec; 10(8):559-64. PubMed ID: 16959520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
    Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
    Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
    Nickers P; Coppens L; de Leval J; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.
    Fuller DB; Koziol JA; Feng AC
    Brachytherapy; 2004; 3(1):10-9. PubMed ID: 15110308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Brachytherapy for prostate cancer].
    Yorozu A; Toya K; Ohashi T; Ohsuga K; Ito R; Kasamatsu T; Saito S; Momma T
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):424-7. PubMed ID: 16612148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
    Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
    Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial.
    Kaplan ID; Meskell PM; Lieberfarb M; Saltzman B; Berg S; Holupka EJ
    Brachytherapy; 2004; 3(1):7-9. PubMed ID: 15110307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds.
    Bottomley D; Ash D; Al-Qaisieh B; Carey B; Joseph J; St Clair S; Gould K
    Radiother Oncol; 2007 Jan; 82(1):46-9. PubMed ID: 17161481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-step customized transurethral resection of the prostate and permanent implant brachytherapy for selected prostate cancer patients: technically feasible but too toxic.
    Cosset JM; Barret E; Castro-Pena P; Cathelineau X; Galiano M; Rozet F; Pierrat N; Timbert M; Vallancien G
    Brachytherapy; 2011; 10(1):29-34. PubMed ID: 21251622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.
    Heysek RV; Gwede CK; Torres-Roca J; Cantor A; Kelley S; Saini AS; Pow-Sang J
    Brachytherapy; 2006; 5(4):244-50. PubMed ID: 17118318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
    Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.
    Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook JM
    Brachytherapy; 2008; 7(2):200-5. PubMed ID: 18362087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography.
    Gillan C; Kirilova A; Landon A; Yeung I; Pond G; Crook J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):688-93. PubMed ID: 16626892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.
    Okaneya T; Nishizawa S; Nakayama T; Kamigaito T; Hashida I; Hosaka N
    Int J Urol; 2007 Jul; 14(7):602-6. PubMed ID: 17645602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
    Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
    Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma.
    Wang Y; Sankreacha R; Al-Hebshi A; Loblaw A; Morton G
    Brachytherapy; 2006; 5(4):251-5. PubMed ID: 17118319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.